Needham analyst Michael Matson maintained a Hold rating on Masimo (MASI – Research Report) today. The company’s shares closed ...

Wells Fargo analyst Vik Chopra has assigned their bullish stance on MASI stock, giving a Buy rating yesterday. Vik Chopra has given his Buy ...

The medial device company claimed that the Apple Watch Series 6 ... including Cercacor’s former chief technology officer and ...

Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...

The consensus rating for Masimo is Buy, based on 2 analyst ratings. With an average one-year price target of $167.5, there's a potential 16.14% upside.

Penumbra and Inspire Medical Systems, providing valuable insights into their respective standings within the industry and their market positions and comparative performance. Masimo ranks at the ...

Apple had been hoping to secure an injunction on the sale of Masimo's medical devices in the US. As it turned out, Masimo beat all but three of the patent infringement claims brought by Apple at ...

Roots Community Health has sued 12 other firms, including GE Healthcare, CVS and Walgreens, and called for manufacturers and ...

Joshua Stowell is a leading litigator and partner at Knobbe Martens, Orange County's largest intellectual property law firm, ...

Surmodics, Inc. SRDX posted a loss per share of 13 cents in the fourth quarter of fiscal 2024 against the year-ago quarter’s ...

QSC LLC, which specializes in audio, visual and control systems, has agreed to be acquired by Atlanta-based Acuity Brands ...